US Broker Ratings

Xencor, Inc. (XNCR) Stock Analysis: Exploring a 26.83% Potential Upside in the Biotechnology Sector

Xencor, Inc. (XNCR), a dynamic player in the biotechnology sector, is drawing attention from investors with its innovative approach to drug development, particularly in the fields..

Akso Health Group (AHG) Stock Analysis: Challenges and Opportunities in China’s Medical Distribution Sector

Akso Health Group (AHG), a player in China’s burgeoning healthcare sector, presents an intriguing case for investors navigating the complex landscape of medical distribution. With a..

Phibro Animal Health Corporation (PAHC) Stock Analysis: A 22.67% Upside Potential Beckons Investors

Phibro Animal Health Corporation (NASDAQ: PAHC) presents a compelling opportunity for investors seeking exposure to the healthcare sector, specifically in the niche of animal health and..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Potential 45% Upside Amid Strong Buy Ratings

Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline of therapies targeting cancer and inflammatory..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 191.65% Upside in the Biotechnology Sector

Sana Biotechnology, Inc. (NASDAQ: SANA), a pioneering force in the biotechnology realm, is making waves with its innovative approach to engineered cell therapies. With a market..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Potential 84% Upside in Biotech Stock

In the dynamic world of biotechnology, Vir Biotechnology, Inc. (NASDAQ: VIR) stands out as a compelling opportunity for investors seeking exposure to the healthcare sector. As..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: Potential 60% Upside Amid Strong Buy Ratings

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a biotechnology firm headquartered in Boulder, Colorado, has recently captured significant investor attention due to its promising pipeline and a robust..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: A 59% Upside with Robust Revenue Growth

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is making waves in the biotechnology sector with its dedicated focus on developing therapies for severe autoimmune diseases. Established in 2019..

Oculis Holding AG (OCS) Stock Analysis: Unveiling a 318.86% Upside Potential Amidst Clinical Advances

For investors with a keen eye on the biotechnology sector, Oculis Holding AG (OCS) presents an intriguing proposition. Based in Zug, Switzerland, this clinical-stage biopharmaceutical company..

Immatics N.V. (IMTX) Stock Analysis: Unveiling a 108.93% Potential Upside for Biotech Investors

Immatics N.V. (NASDAQ: IMTX), a clinical-stage biopharmaceutical company based in Tübingen, Germany, stands at the forefront of developing cutting-edge immunotherapies to combat cancer. Operating within the..

AnaptysBio, Inc. (ANAB) Stock Report: A Deep Dive into 79.42% Potential Upside

AnaptysBio, Inc. (NASDAQ: ANAB) has emerged as a notable player in the biotechnology sector, capturing investor attention with its innovative therapeutic developments and promising financial outlook...

Bicycle Therapeutics plc (BCYC) Stock Analysis: Potential 166.85% Upside Amid Innovative Pipeline

Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector as a clinical-stage pharmaceutical company with a focus on developing a novel class of medicines...

Kura Oncology, Inc. (KURA): Investor Outlook Highlights 199% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA) is generating significant buzz in the biotech sector, particularly among investors seeking high-growth opportunities in the healthcare industry. With a market..

Talkspace, Inc. (TALK) Stock Analysis: Evaluating Growth Potential and 21.43% Upside in the Healthcare Sector

Talkspace, Inc. (NASDAQ: TALK) has emerged as a noteworthy player in the healthcare sector, specifically in the field of health information services. With its innovative approach..

Sionna Therapeutics (SION) Stock Analysis: Unveiling a 311.76% Potential Upside in the Biotech Sector

Sionna Therapeutics, Inc. (NASDAQ: SION), a U.S.-based biotechnology firm, is making waves in the healthcare sector with its pioneering efforts in developing treatments for cystic fibrosis..

Ardelyx, Inc. (ARDX) Stock Analysis: Potential 281% Upside Suggests Major Growth for Investors

Ardelyx, Inc. (NASDAQ: ARDX) is capturing the attention of investors with its impressive growth prospects and potential for significant upside. This biopharmaceutical company, specializing in innovative..

Evolus, Inc. (EOLS) Investor Outlook: Exploring a Potential 95% Upside in the Aesthetic Market

Investors eyeing the healthcare sector might find Evolus, Inc. (NASDAQ: EOLS) a particularly intriguing proposition. Specializing in the cash-pay aesthetic market, Evolus, headquartered in Newport Beach,..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Exploring a 32.82% Potential Upside Driven by Robust Revenue Growth

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a Chicago-based company operating in the healthcare sector, has emerged as a promising player in the specialty and generic drug..

Butterfly Network, Inc. (BFLY): Investor Outlook with 33.65% Potential Upside

Butterfly Network, Inc. (NYSE: BFLY) is making waves in the healthcare sector with its innovative medical devices, particularly in the realm of ultrasound imaging solutions. With..

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Potential 76% Upside Amidst Biotech Innovations

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to addressing disorders linked to dysfunctional..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds